Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson’s disease
Christoph Scherfler(Centre Hospitalier Universitaire de Lille), Klaus Seppi(Innsbruck Medical University), Michael Schocke(Innsbruck Medical University), Bernadette Pinter(Innsbruck Medical University), Clemens Decristoforo(Innsbruck Medical University), Werner Poewe(Innsbruck Medical University), Irene Virgolini(Innsbruck Medical University), Michael Nocker(Innsbruck Medical University), Sabine Spielberger(Innsbruck Medical University), Boris Warwitz(Innsbruck Medical University), Philipp Mahlknecht(University College London), Regina Esterhammer(Innsbruck Medical University), Eveline Donnemiller(Innsbruck Medical University), Heike Stockner(Innsbruck Medical University)
Cited by 66
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k